Our goal was to decipher the cellular mechanisms of how OPG modulates and reprograms the normal mammary epithelial cells to a tumorigenic state thus suggesting promising avenues for treating IBC as well as highly invasive breast cancer with new therapeutic targets [6]. Here, TNFRSF11B is linked to breast carcinoma.